TrialThe Lancet. Oncology2023

Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial.

Cullen M Taniguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.